Advancing Technologies to Improve Delivery of Pharmacological, Gene Editing, and other Cargoes for HIV and SUD Mechanistic or Therapeutic Research (R01 Clinical Trial Optional)
Key Information
Due Date: November 15, 2024
Agency: U.S. Department of Health and Human Services (HHS)
Source: Federal
Funding Category:
Health & Human Services
Funding Amount: Not Specified
Funding Type: Grant
Match Required: No
Contact Info:
grantsinfo@nih.gov
See Section VII. Agency Contacts within the full opportunity announcement for all other inquires.
Overview
This grant, titled "Advancing Technologies to Improve Delivery of Pharmacological, Gene Editing, and other Cargoes for HIV and SUD Mechanistic or Therapeutic Research (R01 Clinical Trial Optional)" is aimed at advancing and developing technologies for better delivery systems. These could include systems for pharmacological purposes, gene editing or other types of cargo. The grant has a focus on HIV and Substance Use Disorder (SUD) research - specifically in mechanistic or therapeutic areas. Activities funded by the grant could potentially include clinical trials, though these are not mandatory. This funding opportunity is purposed towards improvements in treatment and understanding of HIV and SUD through cutting-edge technological advancement.
Show More
Key Dates
Open Date: November 1, 2023
Application Due Date: November 15, 2024
Estimated Award Date: Not Specified
Additional Details
Eligible Activities
- Research and Development
Eligible Applicants
- State governments
- County governments
- City, village or township governments
- Special district governments
- Independent school districts
- Public and State controlled institutions of higher education
- Private institutions of higher education
- Small businesses